Inmune Bio Inc (INMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,678 | -5,360 | -2,293 | -1,901 | -12,440 |
| Other Working Capital | -261 | -973 | -1,120 | -461 | 380 |
| Other Operating Activity | 2,555 | 1,382 | 407 | 975 | 10,001 |
| Operating Cash Flow | $-5,385 | $-4,951 | $-3,006 | $-1,388 | $-2,059 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 12,209 | 12,209 | 12,209 | 7,251 | 900 |
| Financing Cash Flow | $12,209 | $12,209 | $12,209 | $7,251 | $900 |
| Exchange Rate Effect | -15 | -61 | -26 | -1 | -26 |
| Beginning Cash Position | 186 | 186 | 186 | 186 | 1,371 |
| End Cash Position | 6,996 | 7,383 | 9,364 | 6,049 | 186 |
| Net Cash Flow | $6,809 | $7,197 | $9,178 | $5,863 | $-1,185 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,385 | -4,951 | -3,006 | -1,388 | -2,059 |
| Free Cash Flow | -5,385 | -4,951 | -3,006 | -1,388 | -2,059 |